Indication
Stage 1 cT1b-T1cN0M0
1 clinical trial
5 drugs
Clinical trial
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast CancerStatus: Recruiting, Estimated PCD: 2025-09-30
Drug
TiragolumabDrug
mFOLFOX6Drug
R-CHOPDrug
cyclophosphamideDrug
AN0025